Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematological malignancies by Guiot, H.F.L. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
This full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/14787
 
 
 
Please be advised that this information was generated on 2014-11-11 and may be subject to
change.
Scand J Infect Dis 18: 153-160, 1986
Selective Antimicrobial Modulation of the 
Intestinal Microbial Flora for Infection 
Prevention in Patients with Hematologic 
M alignancies
Evaluation of Clinical Efficacy and the Value of Surveillance Cultures
HENRI F. L. G U IO T ,1,2 A N N A  V. H E L M IG -S C H U R T E R ,1 
JOS W. M. VAN DER M E E R 2 and R ALPH  VAN FU R TH 2
From the 1Isolation Ward, J. A. Cohen Institute for Radiopathology and Radiation Protection, 
and the 2Department o f  Infectious Diseases, University Hospital, Leiden, The Netherlands
To confirm the results obtained in an earlier study, the incidence of infection was evaluated in 
54 patients (62 periods of admission), nursed in conventional rooms and given a regimen of 
antimicrobial agents intended to modulate the intestinal flora selectively as a method to 
prevent infection during severe granulocytopenia. In 62 patients receiving selective antimicro­
bial modulation (SAM), 18 % acquired major infections which was similar to 19 % in patients 
on SAM  in an earlier double-blind placebo controlled study and lower than 47 % in the 
controls. Evaluation of a large number of surveillance cultures showed that the presence of 
specific potentially pathogenic aerobic bacteria was associated with the occurrence of major 
infection. If the bacterial species in question were not found in the cultures the chance of 
becoming infected was < 5  %, whereas the chance ranged between 42 and 62 % depending on 
the species involved when these microorganisms were isolated.
H. F. L. Guiot, PhD, Isolation Ward, Bid. 16, University Hospital of Leiden, 2333 AA Leiden, 
The Netherlands
IN T R O D U C T IO N
Since the results of a double-blind placebo controlled study (1) on the effect of our regimen 
for selective antimicrobial modulation (SAM) in patients with acute myelogenous leukemia 
(AM L) had shown that a reduction of the incidence of infection could be obtained with this 
treatment, it was decided to administer SAM  routinely to all patients admitted to our 
hospital who were at risk of becoming severely granulocytopenic. Two years later, we 
wanted to know whether the incidence of infection among such patients was still of the 
same order of magnitude as that in the group of patients on SAM  during the preceding 
study. To this end we compared the results obtained with SAM  during the placebo 
controlled study (September 1977 to October 1981) and the follow-up study (October 1981 
to January 1983). We also used the large series of bacteriological data to re-evaluate 
suggestions concerning the value of surveillance cultures, we had put forward in an earlier 
report (2). The usefulness of these cultures, either as a guide for changes in prophylactic 
measures or for the selection of antimicrobial drugs for treatment has been a controversial 
subject (3- 7). Because of the high costs of this accessorial procedure, the collection of 
more data in this field is a matter of prime importance.
PATIEN TS A N D  M E TH O D S
T h e  pa t ien ts  involved, all adults  at risk o f  becom ing  ex trem ely  granulocytopenic  due to an underlying 
hem ato log ic  d iso rd e r  an d /o r  the appropr ia te  remission induction therapy,  were adm itted  to the 
D e p a r tm e n t  o f  In ternal  M edic ine  o f  the University  Hospital  o f  Leiden between O ctober  1981 and 
J a n u a ry  1983.
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All pa t ien ts  were given SAM  prophylax is  consisting o f  4 capsules  containing a mixture o f  n eom y ­
cin, po lym yxin  B, and am phote r ic in  B. given 4 times daily, and 1 tablet o f  nalidixic acid, given twice 
daily. T he  total dosage  adm in is te red  daily was I g neom ycin ,  1 g amphoteric in  B, 2 g nalidixic acid, 
and  400 mg po lym yxin  B. All pat ien ts  were topically t rea ted  in the nose with a cream containing 0.5 % 
neom ycin  and 0.1 % ch lo rhex id ine  hydrochlor ide  to prevent carriage of S taphy lococcus  aureus .  No 
o th e r  topical an t isep t ics  were used. Most o f  the patients were put on SAM within a few days after 
adm iss ion  as soon as the ir  g ranu locy te  count  d ropped  below 500/(.il. SAM was withdrawn when the 
coun t  rose  above 500/j.il and no fu r ther  hematologic therapy  was given, or  if the attending physicians 
ju d g e d  con t inua t ion  useless  on clinical o r  psychological grounds.
Protective isolation. The  patients  were nursed in conventional single-bed rooms and were only 
perm it ted  to leave the room for exam ina t ion  e lsewhere in the hospital or  for a few days '  stay at home 
beween 2 co u rse s  o f  cy tos ta t ic  therapy .  During the interim period the SAM regimen was continued  at 
hom e.  T he  pa t ien ts  were given conventional  hospital food (1).
Definition o f  infections. Infections were classified as bacterial,  fungal, viral, and pro tozoan.  The 
bacter ia l  and fungal infections were divided into minor infections (clinically manifest infection of the 
skin o r  m u co sa  without ex tens ion  to the blood, deep  tissue, or  organs), and major infections 
(clinically manifest  infection o f  deep  t issue, o r  organs and septicemia).  Infections were called doubtful 
if the d iagnost ic  p ro ced u re s  did not give conclusive results and no response  to antimicrobial therapy 
was obse rved .
A cqu ired  infections were defined as infections in which the first clinical signs appeared  after the 
first week on SA M .
M anagem ent o f  infection. System ic  antibiotic trea tm ent  was not instituted until an infection was 
ser iously  su sp ec ted  o r  proven (1). The  choice o f  antibiotics was governed by the site o f  the infection 
and  the su sp ec ted  causa t ive  m icroorganism s.  W henever  possible,  antibiotic therapy  was adjusted on 
the basis  o f  the results  o f  bacteriological investigation.
Fever. E ach  day on which  a p a t ien t ’s axillary body tem pera tu re  was at least 5=38°C, was defined as 
a day with fever.
Granulocytopenic episodes. A period o f  2 or  more successive days with peripheral blood granulo­
cy te  co u n ts  o f  5Sl00/|il was defined as a period of severe granulocytopenia .  Each period o f  admission 
was split into ep isod es  in which the g ranu locy te  coun ts  were ^100/|.d or  >100/^1.
Bacteriological investigations. Bacteriological surveillance included cultures o f  feces and swabs 
taken  from the nares ,  and  the o ropharyngea l ,  axillary, genitourinary ,  inguineal, and perineal regions. 
T he  sam ples  were co llec ted  once  a week on a fixed day, and plated on routine media (8). Each culture 
yielding an isolate belonging to the E n te robac te r iaceae ,  Pseudom onas  aeruginosa,  and S. au reus ,  was 
co n s id e red  positive for specific potentially pathogenic  microorganisms (SPPM). The SPPM cultured 
from the surveil lance cu ltu res  were s tored  at -2 0 ° C .  In cases  with a microbiologically proven 
infection, the SPPM  strain involved was typed and com pared  with the related strain isolated from 
surveil lance cu l tu res .  E n te ro b ac te r ia ceae  were biochemically  typed (8) in addition to the d e te rm ina ­
tion o f  m orpholog ic  cha rac te r is t ic s  and sensitivity pa tterns  (disc diffusion tests). P. aeruginosa  and S. 
a u re u s  were sent  to the cen tra l  labora to ry  for microbiology in the N ether lands  (The National Institute 
o f  H eal th  and E nv iro nm en ta l  Hygiene, Bilthoven) for typing by phage reactions and serologic and 
b iochem ica l  charac te r is t ic s .  Each  g ranu locy topen ic  episode during which SPPM were cultured were 
called “ S P P M -p o s i t iv e” .
R E SU L T S
Efficacy o f  SAM
O f 60 patients given SAM , 6 patients were excluded because their risk to become 
extremely granulocytopenic was overestimated and as a result they had received SAM  for 
less than 14 days, which was considered too short for reliable assessment of the prophylac­
tic efficacy. Most of the evaluable 54 patients had been treated for acute myelogenous 
leukemia (AM L), acute lymphoblastic leukemia (ALL) in relapse, chronic lymphoblastic 
leukemia (CLL) in blast crisis and severe aplastic anemia (Table I). Seven patients 
(miscellaneous, i.e. hairy-cell leukemia, non-Hodgkin's lymphoma) were at least at less 
serious risk because they had only had a few days with a granulocyte count ^ 100/f.il. Six 
patients had been admitted twice and one 3 times, with breaks of at least one month. Thus, 
62 periods of admission of these 54 patients were evaluated, representing 2294 days on
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Table I. Patient characteristics and state o f  disease
A M L  =  acu te  m ye logenous  leukem ia;  A L L  =  acute  lymphoblastic  leukemia; C L L  =  chronic 
lym phocy t ic  leukem ia  (blast crisis); AA = aplastic anem ia;  Miscellaneous; 2 patients with hairy-cell 
leukem ia ,  and  5 pat ien ts  with n o n -H o d g k in ’s lym phom a
No. o f  Remission upon Mean no. of  days
patien ts  Mean age, yrs hematologic therapy with granulocytes
Diagnosis  (adm issions)  (range) yes/no ^100/f.d
A M L  43 4 5 (18 -72 )  26/17 25
A L L  5 45 (20-68) 4/1 17
C L L  3 61 (56-66) 1/2 22
AA 4 42 (20-50) 1/3 24
M isce l laneous  7 38(18 -61)  7/0 9.5
SAM  prophylaxis. The total number of days of severe granulocytopenia ( ^ 100/jxl) was 
1240, which amounts to a mean of 20 days per period of admission. 35 bacterial infections 
were diagnosed (Table II), 23 of which were acquired (12 minor infections, 11 major 
infections). The acquired major infections were septicemia with gram-negative rods in 7 
patients, septicemia with S. aureus in 2 patients, and bacteremia associated with rectal 
abscesses (Streptococcus faecalis) or infiltration ([5-hemolytic streptococci) in 2 other 
patients. In 5 patients, minor viral infections were observed, i.e. herpes simplex of the lip 
and oral cavity, and viral tonsillitis. No fungal or protozoan infections were diagnosed. In 
7 patients the clinical condition seemed consistent with infection, but convincing evidence 
could not be found (doubtful infections). Eight patients died shortly after the period on 
SA M . All of them had been refractory for hematological therapy, and continuation of 
SAM  was judged to be useless. In 3 of these 8 patients infection contributed to death (2 
patients with S. aureus infection and 1 patient with S. aureus in combination with P. 
aeruginosa).
Comparison o f  the results o f  the follow-up and the placebo controlled study
Comparison of the results of the present retrospective follow-up study, performed during 
the period between October 1981 and January 1983, and those of the placebo controlled
Table II. Occurrence o f  infections in the present study and the placebo-controlled study 
(data from  reference I)
Present study Placebo-controlled studvm
SAM SAM Placebo
No. o f  pa t ien ts 62 16 17
N o .  o f  days /pa t ien ts  with
g ran u lo cy te  c o u n t s ^  100/f.il (range) 20 (0-82) 14 (0-31) 13 (0-24)
Infec t ions"
Tota l  no. o f  infections 35 (56%) 10 (62%) 16 (94%)
Tota l  no. o f  acqu ired  infections 23 (37%) 5 (31%) 11 (65%)
N o. o f  m a jo r  acqu ired  infections 11 (18%) 3 (19%) 8 (47%)
N o. o f  m ajo r  acqu ired  infections with SPPM 9 (14%) 1 (6%) 7 (41%)
° Within b racke ts :  the pe rcen tage  o f  patients  infected
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positive cu ltu re  being e i ther  
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neum , gro ins ,  axillae, vulva or 
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study performed between September 1977 and October 1981 shows that the results of 
SAM  for both studies are similar (Table II). Thus, despite the longer period of granulocy­
topenia ( < 100/|xl) in the patients of the follow-up study, a 50% reduction of the incidence 
of infections was obtained, relative to the placebo group of the former study.
Surveillance cultures and infection
The results of surveillance cultures were also quite similar to those of the first study ( 1). 
The cultures of fecal samples showed SPPM only occasionally (Fig. 1); most of these
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Fig. 2. A ssoc ia t ion  be tw een  species  o f  m icroorgan­
isms causing  infection, and results  o f  surveillance cul­
tu res  in pa t ien ts  with ^ 1 0 0  granulocytes/(.il. SPPM + = 
surveil lance  cu l tu res  positive for SPPM ; S P P M -  = 
surveil lance  cu l tu res  negative for SPPM ; o thers  =  
o th e r  spec ies  o f  bacter ia .  O pen  bars =  minor infec­
t ions;  b lack  bars  =  m ajor  infections.
SPPM
Surveillance Cult.
microorganisms being transient and all of them sensitive to at least one of the SAM drugs. 
SPPM were cultured regularly from the skin, i.e. axillary, genitourinary, and perineal 
areas; however, the oral cavity gave the highest yield. Not only transient gram-negatives 
and S. aureus were found there, but SPPM often persisted longer.
To examine the association between SPPM found in surveillance cultures and infec­
tions, each period of admission was divided into successive days with granulocyte counts 
above or below 100/^1. If SPPM were shown in the surveillance cultures during these 
periods the period was called “ SPPM-positive” .
No association was found between the occurrence of infection and the results of 
surveillance cultures during periods with granulocyte counts >100/|il, since there was only
1 case of infection of any importance, i.e. an axillary abscess. For periods with granulo­
cyte counts ^ 100/(.il, there seemed to be an association. Of 38 granulocytopenic episodes 
with SPPM-positive surveillance cultures, 26 (68%) were associated with infection, versus
10 (35%) of 29 granulocytopenic episodes with surveillance cultures SPPM-negative 
( X 2 = 7 .62, p = 0 .06). With respect to the microorganisms responsible for infections, it was 
found that infections with Enterobacteriaceae, P. aeruginosa and S. aureus occurred most 
frequently in patients with SPPM-positive surveillance cultures (Fig. 2). The incidence of 
infection with other microorganisms, such as streptococci and S. epidermidis, was similar 
for the granulocytopenic episodes with SPPM-positive surveillance cultures and those 
which were SPPM-negative (Fig. 2). About 70% of the infections with SPPM were major 
infections versus 10%  for infections with other bacteria (Fig. 2). With respect to the 
species, it was found that the presence of one species of the SPPM in surveillance cultures 
was often associated with infection caused by the same species (Table III). For example, 
S. aureus was found in the surveillance cultures of 23 patients during periods of severe 
granulocytopenia, and was not found in those of the other 39 patients, whereas infection 
with S. aureus occurred in 48%  of the former versus 5 % of the latter. This means a 
probability (95%  confidence interval) to acquire infection with S. aureus between 27 and 
69% for patients with positive surveillance cultures and between 0.6 and 17% for those 
with negative cultures. 62%  of the patients with surveillance cultures positive for P. 
aeruginosa developed an infection with this species versus 2%  for those negative for it. 
The probability (95%  confidence interval) to acquire infection with P. aeruginosa lies 
between 25 and 91%  if these bacteria are present in surveillance cultures; if not, the 
probability to acquire infection lies between 0 and 10%. Similar results were obtained for
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Table III. Association between individual isolates o f  SP PM  found in surveillance cultures 
and occurring in infections
Figures  within b racke ts :  acqu ired  infections
Surveil lance  cu l tu res  
positive for
Patients  with 
infections Site o f  infection
Yes No
Oral
cavitv Skin
Pneu­
monia
Septi­
cemia
S tap h y lo co ccu s  au reus
Yes II 12 6 (2) 1 (1) 2 (1 ) 2 (2)
N o 2 37 -- I — 1"
P se u d o m o n a s  aerug inosa
Yes 5 J 1(1) 1 — 3 (2)
N o 1 53 — -- — r
E n te ro b a c te r ia c e a e
Yes 8 11 1 --- 5 (4)
N o 1 42 — 1 — ---
a O ne infectious ep isode  with S. au reus  and P. aeruginosa
species of Enterobacteriaceae; i.e. 42% of the patients with positive surveillance cultures 
acquired infection with these bacteria, versus 2%  of the patients in those which were 
negative. The corresponding probabilities to acquire infection lies between 20 and 66% for 
the positive surveillance cultures and between 0 and 12% for the negatives.
In 13/28 of these infections, the association between presence in the surveillance 
cultures and infection was considered to be extremely clear because of the conformity 
between typing results of SPPM cultures from surveillance cultures and from the infection. 
One case report is given as an example below.
C A S E  REPORT
On August  13, an ulcerative lesion developed in the oral cavity of  a 62-year-old patient being treated 
for  A M L . On August  23 and S ep tem b e r  1 and 9, P. aeruginosa  was cultured from oral swabs. The 
patien t  was not given local antimicrobial  trea tm ent in the oral cavity. On S ep tem ber  1, 4, 6. and 9. P. 
ae rug in o sa  was cu ltured  from the blood. All typing charac ter is t ics  o f  these isolates were identical.
D ISCU SSIO N
Patients and infection
The differences observed in a double-blind placebo controlled study on the prophylactic 
effect of SAM  in patients suffering from A M L  ( 1) were significant, and the order of 
magnitude of reduction of the incidence of infection due to SAM seemed to be appreciable. 
However, the 95%  confidence interval was 28% ± 30% ( 1), which means that the real 
effect of SAM  on the incidence of acquired major infection might range from a minimum of
— 2 %  difference with the control group to a maximum of 58% difference. Thus, the 
substantial order of magnitude of the reduction of the incidence of infection we found in 
the patients given SAM  might be fortuitous. The follow-up study presented in this paper 
was therefore performed to test the order of magnitude of the reduction.
The results show an 18% incidence of major acquired infection in 62 patients given
Scand J Infect Dis IS (1986) Selective antimicrobial modulation 159
SAM . This is close to the results obtained in the placebo controlled study, where the 
incidence in 16 patients on SAM was 19%. The patients of the follow-up study were a 
heterogeneous group in contrast to the controlled study, but most of them were treated 
with the same antileukemic regimens for A M L  as those in the first study. Because the 
number of days with granulocyte counts 1^00/|¿1 per patient was higher in the follow-up 
study than in both arms of the former study, we feel that SAM can give an appreciable 
reduction of acquired major infections.
Surveillance cultures and infection
The additional care given to patients with severely decreased host resistance is accompa­
nied by high costs. Therefore, it is important to assess the benefit of each of the 
accessorial procedures. One of the questions to be answered is whether it is valuable to 
perform surveillance cultures and, if so, how often and from what sites. The benefit of 
these cultures whether for the alteration of prophylactic measures or for the choice of 
antimicrobial drugs for therapy is still a subject of controversy (3- 7). Our results show that 
most SPPM were isolated from cultures of oral swabs. This is not surprising since the 
patients were nursed in single rooms, fed normal hospital food and were not given local 
antimicrobial treatment in the oral cavity. It is reasonable to assume that under these 
conditions microorganisms can easily colonize the oral cavity, whose mucosal surfaces are 
affected by cytotoxic therapy (9), whereas in the lower parts of the digestive tract these 
microorganisms are eliminated by the antimicrobials of SAM and the additional effect of 
colonization resistance ( 10- 12). Indeed, the number of SPPM found in feces were small. 
On the skin SPPM were present more often, but probably the skin is less sensitive to the 
cytotoxic treatment leaving its natural defense capacity in part unaffected.
No correlation was found between SPPM-positive surveillance cultures and infection 
during episodes of granulocytopenia as long as the number of granulocytes was higher than 
100/f.il, but the opposite was found during episodes of extremely low granulocyte counts 
( ^ 100/[.il). The high incidence of infection with SPPM species cultures from oral swabs 
indicates that these cultures are important.
Whether the results of surveillance cultures should be taken into account in clinical 
practice may depend on several other factors, e.g. the patient's condition, granulocyte 
counts, the site of lesions or pain, the presence of fever, etc. All diagnostic data and the 
patient's recent history (e.g. the kind of infections during previous therapy) may contrib­
ute to the decisions. It must be kept in mind that even if the surveillance cultures are 
SPPM negative, in a small number of patients infection with SPPM may still occur. We 
have the feeling that in these cases the infections are often already present, either not yet 
clinically manifest or in a “ closed”  system (e.g. persisting soft-tissue infection), that 
prevents the bacteria in question from reaching the sites from which samples are taken for 
surveillance cultures.
The conclusion drawn from the present study is that the findings of surveillance cultures 
must be taken into account, either for additional prophylactic measures or for the treat­
ment of infection.
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